Budget Impact Analysis
Budget impact analysis estimates the financial consequences (net costs or savings) of implementing a new health technology in a specific healthcare system or population over a short time horizon (typically 1–5 years). Distinct from cost-effectiveness analysis (which compares health outcomes per dollar), BIA answers a budgetary question: 'If we adopt this new drug/device, how much will it cost our health system next year?' Widely used by hospital procurement committees, insurance formularies, and government health budgets to assess financial feasibility and reimbursement decision.
Kilderegistrering
Citater kopieret ordret fra metodens kilderegistrering. Ingen påstandsniveauverifikation er udledt heraf.
- Sullivan, S. D., Mauskopf, J. A., Augustovski, F., et al. (2014). Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value in Health, 17(1), 5-14. · DOI 10.1016/j.jval.2013.08.2291
- Klok, R. M., Brouwers, J. R., Postma, M. J., et al. (2005). Budget-impact analysis: a systematic literature review of implementation studies. The Annals of Pharmacotherapy, 39(3), 518-526. · URL
- Canadian Agency for Drugs and Technologies in Health (CADTH). (2017). Guidelines for the Economic Evaluation of Health Technologies: Canada (4th ed.). Ottawa: CADTH. · URL
Kuraterede påstande
Påstande gemt i bevis-loggen, hver med sin egen vurdering.
Denne visning opfinder ikke en påstandsvurdering, når loggen ingen har.
Relaterede metoder
Genereret fra metodegrafen og vist som maskinelt foreslåede relationer — ingen bevispåstand er udledt.